MarketsandMarkets

Vendor Neutral Archive (VNA) Market Poised $3.48 Billion by 2018

The VNA market is segmented on the basis of its delivery mode, deployment model, and supplier type. In the delivery mode segment, on-premise VNA forms the largest segment of the overall VNA marke

 

Dallas, TX -- (SBWIRE) -- 12/10/2013 -- The "Vendor Neutral Archive Market & PACS Market - VNA [On-premise Software, Hybrid & Cloud, Multi-Department & Multi-Site VNA] & Picture Archiving and Communication System [Enterprise, Cardiology & Radiology] - Global Forecast to 2018" analyzes and studies the major market drivers, restraints, and opportunities in North America, Europe, Asia-Pacific, and Rest of the World.

Browse 54 market data tables and 48 figures spread through 215 pages and in-depth TOC on Vendor Neutral Archive Market"
http://www.marketsandmarkets.com/Market-Reports/vendor-neutral-archive-VNA-PACS-market-1255.html
Early buyers will receive 10% customization on this report.

This report studies the global VNA and PACS market over the forecast period of 2013 to 2018. The global VNA market is estimated at $165.3 million in 2013 and is poised to reach $335.4 million by 2018, at a CAGR of 15.2%. At present, the vendor neutral archive (VNA) and picture archiving and communication system (PACS) markets form indispensable segments of the imaging informatics market.

Departmental PACS currently dominates the overall VNA and PACS market with around 86.5% of the total revenue contribution. However, this market is a considerably mature market generating most of the revenues from PACS replacements. Hence, the market is expected to witness a stable CAGR of 5.2% from 2013 to 2018. Enterprise PACS, on the other hand, is growing faster than departmental PACS and is expected to reach $510 million by 2018, at an almost double CAGR.

The major driving factors of the VNA market include the need for centralized storage of standard-compliant imaging data, government initiatives that favor the use of advanced imaging information systems, and technology and cost-related benefits. On the other hand, lack of an established definition of VNA resulting in confusion and data insecurity (breaches) is an issue that restricts market growth. Cloud-based VNAs, emerging markets, and patient-focused systems promise high-growth opportunities in the global VNA market.

In 2013, North America contributes the maximum share to both VNA and PACS markets, with shares of 64% and 48%, respectively. U.K., Germany, and France contribute largely to the European VNA and PACS market, whereas the Asia-Pacific region represents the most promising region owing to the nation and state-wide healthcare IT policies in Australia, China, and Japan. Although the penetration of VNAs in the RoW region is low, the PACS technology is now widely adopted in Latin America and the Middle East.

The global VNA report covers close to 93 developments for 15 major players in the market between the fiscal years 2010 to Q2 2013. The analysis of these developments reveals that agreements, collaborations, partnerships, joint ventures, and partnerships contributed to 37% of these developments. The large contribution of these partnerships can be attributed to the demand for best-of-breed solutions in the VNA market.

The PACS market, on the other hand, is a mature market with several well-established players. The challenges faced by companies providing PACS to the market are retaining their market shares and differentiating their PACS products to meet market requirements, tapping of new customer segments, and increasing penetration rates of their products in emerging regions such as Asia-Pacific and RoW.

Key companies in the VNA and PACS market include Acuo Technologies (U.S.), Agfa HealthCare (Belgium), BridgeHead Software (U.K.), Carestream Health (U.S.), Dell, Inc. (U.S.), GE Healthcare (U.K.), Fujifilm Corporation (Japan), Merge Health (U.S.), McKesson Corporation (U.S.), Philips Healthcare (The Netherlands), Siemens Healthcare (Germany), and TeraMedica (U.S.).

Browse Related Reports:
Interventional Cardiology & Peripheral Vascular Devices Market To 2016 (Embolic Protection, Chronic Total Occlusion, Coronary Atherectomy, Thrombectomy Devices, IVUS & Angiography Catheters, EVAR Stent Grafts, IVC Filters, Stents, Balloons and Accessory Devices) – Global Trends & Competitive Analysis
http://www.marketsandmarkets.com/Market-Reports/interventional-cardiology-peripheral-vascular-devices-market-790.html

Interventional Cardiology & Peripheral Vascular Market (2011 – 2016) (Coronary Stent, Balloon Angioplasty, Aneurysm Repair, IVUS, Angiocath, Atherectomy, Thrombectomy, Plaque Removal, IVC Filters, & Others) Global Trends & Competitive Analysis
http://www.marketsandmarkets.com/Market-Reports/minimally-invasive-interventional-cardiology-devices-market-548.html

About MarketsandMarkets
MarketsandMarkets is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world.

MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services. MarketsandMarkets covers thirteen industry verticals; including advanced materials, automotive and transportation, banking and financial services, biotechnology, chemicals, consumer goods, telecommunications and IT, energy and power, food and beverages, industrial automation, healthcare IT, medical devices, pharmaceuticals, semiconductor and electronics, aerospace & defense.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Contact:
Mr. Rohan
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: +1-888-600-6441
Email: sales@marketsandmarkets.com
Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets